AIM2 and osteosarcoma: Finally, we constructed a nomogram on the basis of AIM2/PKIB expression–based risk score to predict prognosis of the 1-, 2-, 3-, and 5-year OS of patients with osteosarcoma, offering clinical value for prognosis prediction and support osteosarcoma treatment decision process.